Lactobacillus is widely considered a beneficial bacterium, but it can cause harm in specific circumstances. It plays a well-documented role in tooth decay, can overgrow in the vaginal tract causing painful symptoms, and in rare cases enters the bloodstream to cause serious infections, particularly in people with weakened immune systems. The risk is low for most healthy adults, but understanding when and how Lactobacillus turns harmful matters, especially given its widespread use in probiotics and fermented foods.
Its Role in Tooth Decay
Lactobacillus is one of the key bacteria behind the progression of dental cavities. While it typically doesn’t start the process (that role belongs to another group of bacteria called mutans streptococci), Lactobacillus moves in once early damage has begun and accelerates the destruction. It thrives in the small crevices and rough surfaces created by initial enamel breakdown, where it ferments sugars from your diet and produces lactic acid as a byproduct.
That lactic acid is the real problem. It dissolves tooth mineral in a process called demineralization, and Lactobacillus is particularly good at surviving in the acidic environment it creates. Most competing bacteria can’t tolerate such low pH, so Lactobacillus essentially builds itself a niche where it dominates and keeps driving the cavity deeper. Studies consistently find these bacteria in active cavities but largely absent in children without cavities, making Lactobacillus counts a useful marker of cavity risk in dental assessments.
Vaginal Overgrowth and Cytolytic Vaginosis
In the vagina, Lactobacillus normally plays a protective role by keeping the pH acidic enough to ward off infections. But too much of it causes a condition called cytolytic vaginosis, where the excess bacteria begin breaking down vaginal lining cells. This produces itching, burning during urination, pain during sex, and a white, cottage cheese-like discharge that looks nearly identical to a yeast infection.
The resemblance to yeast infections is what makes this condition tricky. Many people are treated repeatedly for candida that isn’t actually there. Cytolytic vaginosis is diagnosed by what’s absent: no yeast cells, no harmful bacteria, and no white blood cells on a microscopy slide, but a striking overgrowth of Lactobacillus with visible evidence of cell destruction. The vaginal pH stays in its normal acidic range of 3.5 to 4.5, and yeast cultures come back negative. Symptoms tend to flare in the second half of the menstrual cycle, when hormonal changes encourage Lactobacillus growth. The condition is treated by raising vaginal pH, typically with baking soda preparations, rather than with antibiotics or antifungals.
Bloodstream Infections and Endocarditis
In rare cases, Lactobacillus can enter the bloodstream and cause bacteremia, a potentially life-threatening infection. From the bloodstream, it can settle on heart valves and cause infective endocarditis. A comprehensive review of published endocarditis cases found 82 patients across 77 studies, reflecting just how uncommon this is. Among those patients, 65% developed fever, about 28% developed sepsis, and roughly a quarter experienced heart failure. The overall mortality rate was 17%, with patients who had prosthetic heart valves or who went into shock facing the highest risk of death.
Bacteremia from Lactobacillus carries significant mortality even outside of endocarditis. Estimates put the death rate at around 30%, though not all deaths are directly caused by the bacteremia itself, since these patients are often already severely ill. One study found that 48% of patients with Lactobacillus bacteremia had died within a year of diagnosis, and another reported a one-year mortality as high as 69%. These numbers reflect the fact that Lactobacillus bloodstream infections overwhelmingly occur in people who are already medically fragile.
Who Is Most at Risk
Healthy people with intact immune systems almost never develop invasive Lactobacillus infections. The bacteria lack the aggressive traits of typical pathogens and generally can’t overcome a functioning immune response. The danger concentrates in specific groups: people undergoing chemotherapy, organ transplant recipients on immunosuppressive drugs, critically ill patients in intensive care, and those with structural heart problems like prosthetic valves.
Premature infants represent another vulnerable population. A systematic review identified 32 cases of probiotic-related sepsis in preterm neonates, with Lactobacillus responsible for 10 of them. The majority were born before 32 weeks of gestation, and most had other medical complications. Two neonatal deaths were reported across all cases, though the vast majority recovered with antibiotic treatment. The review concluded that probiotic sepsis in preterm infants is relatively rare but remains a concern significant enough to make neonatal units cautious about routine probiotic use.
Cancer patients deserve particular caution. Multiple cases of Lactobacillus bacteremia have been reported in people undergoing chemotherapy, where the immune system’s ability to clear bacteria from the blood is severely compromised. Sepsis, the body’s overwhelming and dangerous response to infection, has occurred in immunosuppressed and critically ill patients who were taking probiotics containing Lactobacillus GG, one of the most commonly used probiotic strains.
Which Species Cause the Most Problems
Not all Lactobacillus species pose equal risk. A review of infection case reports over a recent three-year period found that Lactobacillus rhamnosus was the most frequently implicated species, appearing in 13 cases. This is notable because L. rhamnosus, especially the GG strain, is one of the most widely used probiotic organisms in the world. Lactobacillus paracasei followed with 7 cases, then Lactobacillus acidophilus and L. jensenii with 5 cases each. Lactobacillus plantarum appeared in 3 cases, and several other species were responsible for isolated incidents.
The pattern is clear: the species most commonly used in commercial probiotics are also the ones most frequently reported in infections. This doesn’t mean these probiotics are dangerous for the general population. It likely reflects both how widespread their use is and how closely they’re studied compared to less common species.
Antibiotic Resistance Transfer
One of the less obvious ways Lactobacillus can cause harm has nothing to do with direct infection. These bacteria can carry antibiotic resistance genes and potentially pass them to disease-causing bacteria through a process called horizontal gene transfer. This means Lactobacillus in your gut or in fermented food products could, in theory, share genetic instructions for resisting antibiotics with harmful bacteria like Salmonella or E. coli, making those infections harder to treat.
The resistance genes of greatest concern are those carried on mobile genetic elements like plasmids and transposons, small pieces of DNA that can jump between bacteria. Genes conferring resistance to tetracycline and erythromycin, two commonly used antibiotics, have been identified across multiple Lactobacillus species. L. rhamnosus, L. paracasei, and L. casei, which again are the most popular probiotic species, are the most commonly documented carriers. Lactobacillus strains used in dairy production and present in agricultural settings are also a concern, since they can act as reservoirs of resistance genes in the food chain. Even if a Lactobacillus strain doesn’t express resistance itself, it can still transfer the genes to bacteria that will.
Why Diagnosis Is Often Delayed
When Lactobacillus does cause an infection, identifying it as the culprit can be slow. The genus contains over 170 species that look very similar under standard laboratory testing and often require molecular techniques like DNA sequencing to tell apart. Because Lactobacillus is a normal resident of the gut and vaginal tract, lab technicians may initially dismiss it as a contaminant rather than the source of infection. This is especially problematic in blood cultures, where assuming a Lactobacillus finding is insignificant could delay treatment in a vulnerable patient. The combination of taxonomic complexity and the assumption that “good bacteria” can’t cause harm creates a diagnostic blind spot that clinicians are increasingly aware of but that still contributes to delayed care.